Daiwa Securities Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Daiwa Securities Group’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-87	Closed	-$3K	–	1305
2021 Q1	$3K	Hold	87	–	–	﹤0.01%	1129
2020 Q4	$1K	Buy	+87	New	+$1.09K	﹤0.01%	1249
2019 Q4	–	Sell	-160	Closed	-$1K	–	1267
2019 Q3	$1K	Hold	160	–	–	﹤0.01%	1174
2019 Q2	$1K	Hold	160	–	–	﹤0.01%	1198
2019 Q1	$2K	Hold	160	–	–	﹤0.01%	1150
2018 Q4	$1K	Hold	160	–	–	﹤0.01%	1138
2018 Q3	$2K	Hold	160	–	–	﹤0.01%	1136
2018 Q2	$3K	Hold	160	–	–	﹤0.01%	1130
2018 Q1	$3K	Buy	+160	New	+$3.12K	﹤0.01%	1110

Daiwa Securities Group's FPRX Position: Q2 2021 in Review

Daiwa Securities Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 87 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in FPRX in Q1 2018 and held it in 9 quarters. The position peaked at $3K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Daiwa Securities Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Daiwa Securities Group sold 87 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $3K.
Daiwa Securities Group first reported a position in Five Prime Therapeutics, Inc. in Q1 2018 and held it in 9 quarters.
Daiwa Securities Group's Five Prime Therapeutics, Inc. position peaked at $3K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.